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Maternal stress or sleep 
during pregnancy are not reflected 
on telomere length of newborns
Antti‑Jussi Ämmälä1,2*, Emma I. K. Vitikainen  3, Iiris Hovatta  4,5,6, Juulia Paavonen7,8, 
Outi Saarenpää‑Heikkilä9,10, Anneli Kylliäinen11, Pirjo Pölkki12, Tarja Porkka‑Heiskanen5 & 
tiina paunio1,2,5
Telomeres play an important role in maintaining chromosomal integrity. With each cell division, 
telomeres are shortened and leukocyte telomere length (LTL) has therefore been considered a marker 
for biological age. LTL is associated with various lifetime stressors and health‑related outcomes. 
Transgenerational effects have been implicated in newborns, with maternal stress, depression, 
and anxiety predicting shorter telomere length at birth, possibly reflecting the intrauterine growth 
environment. Previous studies, with relatively small sample sizes, have reported an effect of maternal 
stress, BMI, and depression during pregnancy on the LTL of newborns. Here, we attempted to 
replicate previous findings on prenatal stress and newborn LTL in a sample of 1405 infants using a 
qPCR‑based method. In addition, previous research has been expanded by studying the relationship 
between maternal sleep quality and LTL. Maternal prenatal stress, anxiety, depression, BMI, and 
self‑reported sleep quality were evaluated with self‑reported questionnaires. Despite sufficient power 
to detect similar or even considerably smaller effects than those previously reported in the literature, 
we were unable to replicate the previous correlation between maternal stress, anxiety, depression, 
or sleep with LTL. We discuss several possible reasons for the discrepancies between our findings and 
those previously described.
Intrauterine growth can be seen both as a special environment and a developmental period that shapes future 
health and disease of a  child1. Several maternal factors such as maternal physical, biological, psychological, and 
behavioural conditions can have an effect on this development via multiple channels (immunological, hormonal, 
and metabolic pathways). The effect of these pathways might be seen in Leukocyte Telomere length (LTL) of a 
child. As most cell divisions happen during the early stages of development, critical environmental factors that 
affect cell division and LTL may have the greatest effect during this time period. Several studies support this 
 reasoning1–5. This chain of association from maternal health, LTL of a child, and child’s future health is called the 
Fetal Programming of Telomere Biology  hypothesis1. It postulates that the intrauterine environment in part influ-
ences TL at birth, which in turn may regulate future development and eventually even morbidity and  mortality6,7.
Telomeres play an important role in maintaining chromosomal integrity. Telomeres consist of repetitive DNA 
sequences at the end of each chromosome and a surrounding protein complex, which protects the end of the 
 chromosome8. In each cell division, this sequence is shortened due to an end-replication problem and it inevitably 
open
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reaches a critical point where chromosomal structure and integrity cannot no longer be maintained, resulting 
in a signaling cascade leading to apoptosis. Telomere length is determined by both genetic and environmental 
factors, often interacting with each other, making leukocyte telomere attrition both a causal and a potentiating 
factor for health and  disease9. Age is a major contributor to this shortening and relative leukocyte telomere length 
(LTL) is thought to serve as an indicator of biological  aging5.
In addition to chronological age, lifestyle factors such as smoking or excess alcohol consumption, and other 
factors such as body mass index (BMI), can also have an effect on telomere  shortening10–12. Thus, aging is a 
dynamic process and reciprocal to many environmental and health-related factors. Indeed, shortened TL has 
previously been associated with several somatic and psychiatric diseases and conditions in  adulthood13–15. LTL 
is also associated with mortality and  morbidity16–19. Although heritability estimates for TL are as high as 70%, 
genetic studies are able to predict only a minor component of this  variation12,20,21. Therefore, environmental 
factors clearly have a significant influence on leukocyte telomere length (LTL).
Only a few studies have explored the effect of various maternal and pregnancy-related factors on the LTL of 
the newborn child. Among the most studied factors is maternal stress during  pregnancy22–25. For example, in a 
sample of 319 newborns, maternal stress during pregnancy was associated with shorter newborn LTL. This stress 
did not affect the mothers’ LTL, however, which suggests vulnerability in early stages of  development22. Another 
interesting finding in the same study was that the mothers’ lifetime psychiatric morbidity correlated with the 
LTL of the mother, but not the offspring.
In addition to stress, an association between the maternal pre-pregnancy weight and LTL of newborns has 
also been shown, with shorter child LTL associated with increased pre-pregnancy weight of the  mother26,27. Some 
of these findings were only observed in male  offspring26. Similar findings were also observed between maternal 
education and telomere  shortening28.  Ethnicity29, maternal  smoking26, gestational  diabetes30, and maternal folate 
 concentration31 and  depression26 have also been associated with newborn LTL.
Only anecdotal knowledge exists regarding the effect of maternal sleep during  pregnancy26,27,32,33 on new-
born LTL. Disordered sleep is common during  pregnancy33,34 and may have serious fetal consequences, such as 
impact on growth or other pregnancy-related outcomes. Disturbed sleep is especially common towards the end 
of pregnancy, such as in the third  trimester34. We sampled 1405 newborns for LTL and tested for associations 
with maternal prenatal insomnia and snoring. In addition, using a dataset two to five times larger than those 
previously reported, we tested the robustness of previous associations between newborn LTL and maternal stress, 
anxiety, depression, and BMI during pregnancy.
Results
Analysis of correlations between prenatal variables and leukocyte telomere length of a new‑
born.  Of all explored variables, anxiety (STAI) (β − 0.09, p = 0.04) and BMI (β − 0.01, p = 0.04) had a nomi-
nal significant negative association between prenatal variables and newborn LTL (Tables 1, 2 and 3; see also 
Fig. 1a–e). However, neither survived the correction (FDR) for multiple testing (STAI p  FDRcorr = 0.12, BMI 
 pFDRcorr = 0.12). In most cases, the estimates were below the minimum detectable level calculated in power 
analysis (> 0.07).
Discussion
We found no associations between the quality of mothers’ sleep during pregnancy and LTL of newborn children, 
as measured from blood leukocytes sampled at birth. We were also unable to replicate previous findings related 
to maternal wellbeing during pregnancy and newborn LTL, despite our sample size outnumbering most previous 
Table 1.  Linear regression model with Leukocyte Telomere length as a dependent variable and depression 
(CESD); plate; child ‘s gender; maternal smoking; maternal BMI; gestational age at birth; and maternal BNSQ 
total score and snoring (BNSQ16) as explanatory variables. STAI = Short version of State and Trait anxiety 
Scale, Trait version; CES-D = Center for Epidemiological Studies Depression Scale; PSS = Perceived Stress 
Scale; BNSQ total score = Basic Nordic Sleep questionnaire total score;BNSQ 16 = Question “do you snore?” 
dichotomized as “yes” or “no”; BMI = Height in meters/weight2.
Unstandardized coefficients
Standardized 
coefficients
t Sig
95% confidence interval for B
B SE Beta Lower Bound Upper Bound
(Constant) 2.37 0.38 6.19 0.00 1.62 3.12
Plate 0.01 0.00 0.12 4.05 0.00 0.01 0.01
Gender − 0.03 0.02 − 0.04 − 1.44 0.15 − 0.08 0.01
Gestational age at birth 0.00 0.00 − 0.05 − 1.70 0.09 0.00 0.00
BMI − 0.01 0.00 − 0.06 − 1.94 0.05 − 0.01 0.00
Smoking 0.04 0.05 0.02 0.76 0.44 − 0.06 0.14
BNSQ total score 0.00 0.00 − 0.02 − 0.59 0.56 − 0.01 0.01
BNSQ16 0.03 0.03 0.04 1.30 0.19 − 0.02 0.09
CESD 0.00 0.02 − 0.01 − 0.16 0.87 − 0.05 0.04
a. Dependent variable: LTL
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studies. Increased maternal anxiety, as measured with a standard questionnaire during the last trimester (STAI), 
was associated with shorter LTL, but this result did not remain significant after correcting for multiple testing. 
Associations between maternal wellbeing and newborn telomere length should be carefully considered, and there 
may be multiple reasons for the discrepancies between our results and those previously reported.
First, differences in the LTL analysis method may be a source of undesired variation and thus make it difficult 
to replicate findings. Most studies used quantitative real-time PCR as we did, but some also used a restriction-
enzyme–based approach. Some studies performed analysis in triplicates, while others performed duplicates and 
some did not clearly report this phase of the analysis. Again, even using the same kind of methodology, we could 
not replicate previous findings on the effect of maternal stress during  pregnancy22 .The qPCR method is prone to 
large between-sample variation and measurement error, which can obscure patterns even when between-plate 
variation in T/S is taken into account. Furthermore, maternal effects on newborn LTL may also manifest as a 
shift in the distribution of long versus short  telomeres24; if this was the case, a method based on measuring the 
average relative LTL would not necessarily detect these effects.
Second, the statistical models used in the analyses varied between studies. Most studies used maternal-related 
covariates such as maternal age, maternal BMI, or smoking. Some studies also used pregnancy-related covariates 
such as diabetes, preeclampsia, or number of previous pregnancies. When using a linear model with multiple 
explanatory factors that can be causative for each other, a collider bias might  exist35. For example, maternal high 
BMI might have an effect on child’s  LTL26 as well as maternal  diabetes30. However, high BMI can be partially 
causative for diabetes, introducing a colliding effect. Furthermore, many studies used child-related covariates 
Table 2.  Linear regression model with Leukocyte Telomere length as a dependent variable and anxiety (STAI); 
plate, child ‘s gender; maternal smoking; maternal BMI; gestational age at birth; and maternal BNSQ total score 
and snoring (BNSQ16) as explanatory variables. STAI = Short version of State and Trait anxiety Scale, Trait 
version; CES-D = Center for Epidemiological Studies Depression Scale; PSS = Perceived Stress Scale; BNSQ 
total score = Basic Nordic Sleep questionnaire total score;BNSQ 16 = Question “do you snore?” dichotomized as 
“yes” or “no”; BMI = Height in meters/weight2 .
Unstandardized coefficients
Standardized 
coefficients
t Sig
95% confidence interval for B
B SE Beta Lower bound Upper bound
(Constant) 2.51 0.39 6.50 0.00 1.75 3.27
Plate 0.01 0.00 0.11 3.92 0.00 0.00 0.01
Gender − 0.03 0.02 − 0.03 − 1.21 0.23 − 0.07 0.02
Gestational age at birth 0.00 0.00 − 0.05 − 1.61 0.11 0.00 0.00
BMI − 0.01 0.00 − 0.06 − 2.08 0.04 − 0.01 0.00
Smoking 0.03 0.05 0.02 0.59 0.55 − 0.07 0.12
BNSQ total score 0.00 0.00 − 0.01 − 0.19 0.85 − 0.01 0.01
BNSQ16 0.04 0.03 0.04 1.51 0.13 − 0.01 0.09
STAI − 0.09 0.05 − 0.06 − 2.05 0.04 − 0.18 0.00
a. Dependent variable: LTL
Table 3.  Linear regression model with Leukocyte Telomere length as a dependent variable and stress (PSS); 
plate; child ‘s gender; maternal smoking; maternal BMI; gestational age at birth; and maternal BNSQ total score 
and snoring (BNSQ16) as explanatory variables. STAI = Short version of State and Trait anxiety Scale,Trait 
version; CES-D = Center for Epidemiological Studies Depression Scale; PSS = Perceived Stress Scale; BNSQ 
total score = Basic Nordic Sleep questionnaire total score;BNSQ 16 = Question “do you snore?” dichotomized as 
“yes” or “no”; BMI = Height in meters/weight2 .
Unstandardized coefficients
Standardized 
coefficients
t Sig
95% confidence interval for B
B SE Beta Lower bound Upper bound
1 (Constant) 2.34 0.38 6.19 0.00 1.60 3.08
Plate 0.01 0.00 0.11 3.90 0.00 0.00 0.01
Gender − 0.03 0.02 − 0.03 − 1.19 0.24 − 0.07 0.02
Gestational age at birth 0.00 0.00 − 0.05 − 1.61 0.11 0.00 0.00
BMI − 0.01 0.00 − 0.06 − 2.00 0.05 − 0.01 0.00
Smoking 0.03 0.05 0.02 0.57 0.57 − 0.07 0.12
BNSQ total score 0.00 0.00 − 0.02 − 0.72 0.47 − 0.01 0.00
BNSQ16 0.04 0.03 0.04 1.43 0.15 − 0.01 0.09
PSS 0.00 0.00 − 0.01 − 0.19 0.85 − 0.01 0.01
a. Dependent Variable: LTL
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Figure 1.  Maternal prenatal factors and their association with Child’s Telomere length at birth. (a) Association 
between maternal depression (p = 0.87) and child’s TL at birth. (b) Association between maternal anxiety 
(p = 0.04) and child’s TL at birth. (c) Association between maternal stress (p = 0.85) and child’s TL at birth. (d) 
Association between maternal BMI (p = 0.04) and child’s TL at birth. (e) Association between Maternal sleep 
(p = 0.65) and Child’s TL at birth. Linear regression lines: DotDashline(.-.-.-.-) = all, Dashed line(---) = Males, 
Solid line (___) females. BNSQ = Basic Nordic Sleep questionnaire; CES-D = Center for Epidemiological Studies 
Depression Scale; STAI = Short version of State and Trait anxiety Scale,Trait version;PSS = Perceived Stress Scale; 
BMI = Height in meters/weight2; LTL = relative leukocyte telomere length.
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such as gender, ethnicity, birth weight, and gestational age. The statistical model used most often was a linear 
model constructed from different sets of the aforementioned factors. Other models were also used, such as 
arranging weight gain into  groups29. Despite using the same kind of model as previously  reported22 with only 
Perceived stress scale (PSS) as a predictor of LTL, we were unable to replicate findings related to PSS (β − 0.00, 
p = 0.661), Supplement S1.
A third source of variation may be the different cell populations present in umbilical blood samples. If dif-
ferent leukocyte types have different TL, differences among individuals might not reflect true differences in LTL 
as much as differences in distributions of types of leukocytes among  individuals36. This so-called “tissue issue” is 
familiar in the field of epigenetics, particularly in methylation studies, where good algorithms have been devel-
oped to adjust or control for this  issue37. In LTL studies, however, such an algorithm would not be applicable 
and ways to control differences in white-blood-cell populations between samples are not typically used. When 
TL measured in white blood cells collected from umbilical cord samples were compared with TL measured 
from placental tissue cells, there were no differences in TL between different tissues of  origin27. In our sample 
(n = 1405) we could hypothesize that sample size is sufficient such that the cell populations among samples would 
be normally distributed making this an unlikely source of bias in our findings. However, typical sample sizes 
in previous studies vary, from a few dozen to a few hundred individuals, and only two previous  studies22,27 had 
sample sizes over three hundred. Therefore, one might not automatically expect a normal and even distribution 
of white-blood-cell types across individual samples within a small sample size.
Finally, measures of maternal wellbeing and the timing of measurements varied between studies. In this study, 
maternal predictors (phenotypes) were collected using partly different questionnaires than in previous studies. 
As different questionnaires might have different psychometric properties, such as sensitivity and specificity, they 
can partially measure different phenomena. In previous studies, questionnaires were used as either continuous 
or dichotomized, yielding slightly different results. Furthermore, cut-off points for dichotomizing varied, as 
well as the timing of questionnaires during pregnancy. Yet, we could not replicate previous findings even when 
we used the same well-validated questionnaire (PSS) in the same way and in the same trimester as in a prior 
 study22. Another line of evidence that links maternal wellbeing to offspring LTL comes from studies assessing 
maternal stress through physiological measures, such as hair cortisol. Circulating glucocorticoids are a potential 
mechanism of telomere attrition, but the relationship between experienced stress and cortisol output depends on 
many other factors, such as individual coping  style38. One possible mechanism behind the fetal programming of 
telomere biology-hypothesis1 is the effect of the maternal HPA axis on newborns’ telomeres. Indeed, stress can 
have a shortening effect on LTL via the HPA-axis39. This effect coud be modified during pregnancy, however, by 
both fetal gender-related specific effects on maternal cortisol levels, and a a gender-specific effect of maternal 
cortisol on newborns’  LTL40. In addition to fetal gender, many lifestyle, socioeconomic, and biological factors—
such as maternal smoking, being unemployed, BMI, c-reactive protein, and gestational age, as well as sampling 
time—were associated with maternal cortisol levels during  pregnancy41. Psychosocial stress, however, had no 
effect on maternal cortisol levels during pregnancy. Another study found contrary results indicating an effect 
of maternal psychosocial stress on cortisol levels during  pregnancy42. Besides cortisol, other mechanisms such 
as TNFα-mediated shortening of telomeres have also been  reported43. Careful consideration regarding consist-
ency and the relationship between different measures of maternal wellbeing is therefore needed. For example, 
trajectories af maternal wellbeing during  pregnancy44 could be associated with outcomes, instead of relying on 
questionnaire items at single timepoints, or multiple analyses using correlated predictors.
Many of the aforementioned aspects that may cause heterogenity between studies have been identified in a 
recent large meta-analysis of early adversities and  LTL45. It is worth noting that of 41 studies included in this 
meta-analysis, only two used umbilical-cord blood samples as a source of tissue and thus no definite conclusions 
could be drawn relative to newborns without additional data.
There are several strengths in our study: Our sample size is large, the study is population-based, and samples 
are collected from a defined geographical region. All measurements of maternal wellbeing were conducted at the 
same timepoint during the third trimester, with well-validated  questionnaires46. In addition, all measurements 
of LTL were performed in the same laboratory, at the same time, ensuring a high quality of analysis.
Some weaknesses do appear. Due to the fact that this is a population-based sample, only a minority of sub-
jects suffered from severe stress, anxiety, or clinically significant depression, which could be expected to affect 
the child through fetal  programming1. Self-reported stress during pregnancy was low in our sample—the mean 
score for PSS was 5.67 (SD = 2.83). In a clinical or high-risk sample, associations absent from this study might 
be detectable. For example, smoking had no effect on newborns’ LTL, similar to a previous study by Send et al.22. 
Smoking during pregnancy is quite rare in population-based samples; in our sample, only 5.7% of all mothers 
reported smoking during pregnancy. We did not observe an effect of maternal sleep on newborn LTL. This might 
suggest that sleep has no effect, or that different measurements of sleep are required to detect such an effect. In 
our population-based sample, the number of cases with severe sleep disturbances was small; it is possible that 
an effect would be detectable in case–control studies.
In conclusion, there may be multiple reasons for the diversity of findings observed concerning newborn LTL 
and various maternal-related factors, such as stress during pregnancy, anxiety, depression, or pre-pregnancy BMI. 
As solid evidence exists that these factors do have an effect on a child’s  development47–49, research into the pos-
sible molecular mechanisms is needed. Although LTL might serve as a marker for a good outcome measurement 
for these factors, methodological considerations should be vigorous in order to improve the reproducibility of 
findings. A publication bias might also exist, as there are no published negative findings on newborn LTL and 
various maternal and pregnancy-related topics.
6Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:13986  | https://doi.org/10.1038/s41598-020-71000-2
www.nature.com/scientificreports/
Materials and methods
Samples.  We used a large prospective Finnish birth cohort—the CHILD-SLEEP (CS)  cohort46. A prenatal 
questionnaire on sleep quality, stress, depression, and anxiety was administered during the third trimester (ges-
tation week 32).
The CS cohort was recruited from the Pirkanmaa Hospital District in Finland. Ethical approval was granted 
from the Pirkanmaa Hospital District ethical committee. All methods were performed in accordance with the 
relevant guidelines and regulations, and written informed consent was obtained from all participants. Parent’s 
informed consent was obtained for newborns. All children were born between 2011 and 2013. LTL was measured 
from a total of 1405 newborns (91.8% of all children with DNA available). The characteristics of our sample are 
described in Table 4. Children were born by spontaneous vaginal birth in 82.4% of cases, with vacuum-assisted 
vaginal birth in 7.5%, by elective cesarean section in 2.9%, and by acute cesarean section in 7.2%. The following 
variables were calculated from the study questionnaires: Maternal stress during pregnancy was evaluated with 
the short version of the Perceived Stress Scale (PSS)50. The scale measures perceived stress on a five-point scale. 
Summary scores ranged from 0 to 17 and Cronbach’s α for total score was 0.67. Maternal depression during 
pregnancy was evaluated with the Center for Epidemiological Studies Depression Scale (CES-D)51. The range 
of total scores was 2–23 (Cronbach’s α 0.78). Maternal anxiety during pregnancy was measured with the Short 
version of State and Trait anxiety Scale, Trait version (STAI)52. Total scores ranged from 6 to 21; Cronbach’s 
α was satisfying (0.78). Sleep quality was evaluated with The Basic Nordic Sleep questionnaire (BNSQ)53. The 
questionnaire has 21 items that measure self-reported sleep quality, sleep latency, sleep duration, and tiredness, 
among other measures. We calculated the insomnia score from BNSQ by summing up insomnia-related questions 
(BNSQ 1, 3, 4, 5, and 6) into a total insomnia score. This score ranged from 5 to 25 (Cronbach’s α 0.70). Snoring 
was dichotomized from BNSQ question 16 (“Do you snore?”); snoring one to two times a week or more was 
considered as a case. Smoking was evaluated with the question “Have you smoked during last 6 months?”; those 
who provided a “yes” answer were considered a smoker. Pre-pregnancy BMI was calculated from self-reported 
weight divided by self-reported  height2 .
Power analysis.  We performed power calculations based on the literature to explore whether our sample 
was sufficient to replicate previous findings regarding pregnancy-related maternal variables and their associa-
tion with newborn LTL. We selected maternal stress, BMI, smoking during pregnancy, depression, and anxiety 
during pregnancy as variables of interest. As there were no previous studies regarding sleep quality on LTL, we 
used sleep apnea in adults as a source for effect size. We extracted the effect size and error level from selected 
publications (Table 5). From our analyses, the power varies from 0.89 to 0.999.
Measurement of leukocyte telomere length.  LTL was measured from DNA extracted from peripheral 
blood taken from the umbilical cord at birth. DNA extraction from K2-EDTA-blood tubes was performed using 
magnetic bead technology with a PerkinElmer chemagic 360 instrument (Waltham, MA.USA) and CMG-704 
kit.
DNA was eluted in 400 µl 10 mM Tris–EDTA elution buffer (PerkinElmer). DNA concentration was measured 
with a Quant-iT™ PicoGreen™ dsDNA Assay Kit. Samples were aliquoted with Tecan Genesis/Tecan Freedom Evo 
Table 4.  Characteristics of study sample. BMI = Body Mass Index, self-reported weight divided by self-
reported  height2; STAI = Short version of State and Trait anxiety Scale,Trait version; PSS = Perceived Stress 
Scale; CES-D = Center for Epidemiological Studies Depression Scale;Apgar = 5-min Apgar score; BNSQ 
16 = Question “do you snore?” dichotomized as “yes” or “no”.
Continous variables Mean SD n
Maternal age 30.64 4.57 1323
Maternal BMI (kg/m2) 28.43 4.42 1351
Anxiety (STAI) 8.91 2.37 1390
Depression (CES-D) 7.01 3.42 1348
Stress (PSS) 5.67 2.83 1377
BNSQ insomnia score 14.80 3.31 1393
Child´s gestation age at birth, days 280.70 8.51 1340
Birth weight (g) 3597 449 1414
Birth weight 25% percentile( g) 3295
Birth weight 50% percentile (g) 3580
Birth weight 75% percentile(g) 3880
Apgar score 5 min 8.64 1.40 1337
Dichotomous variables n (cases) % n (controls) % Total
Maternal Snoring (BNSQ16) 330 (25%) 991 (75%) 1321
Maternal smoking 79 (5.7%) 1308 (94.3%) 1387
Child´s gender M = 693 (51.7%) F = 647 (48.3%) 1340
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(Tecan Trading AG, Switzerland) and shipped on dry ice for genetic analyses. DNA extraction was performed 
at the THL Biobank.
To measure LTL, we used a qPCR-based method as described  previously54–57. We used β-hemoglobin (Hgb) 
as a single-copy reference gene. Separate reactions for telomere and Hgb reaction were performed in paired 
384-well plates, in which matched sample well positions were used. Ten nanograms of DNA were used for each 
reaction, performed in triplicate. Every plate included a seven-point standard curve, which was used to create 
a standard curve and to perform absolute quantification of each sample. Samples and standard dilutions were 
transferred into the plates using a multichannel pipet and dried overnight at room temperature. A specific reac-
tion mix for the telomere reaction included 270 nM tel1b primer (5′-CGG TTT (GTT TGG )5GTT-3′) and 900 nM 
tel2b primer (5′-GGC TTG (CCT TAC )5CCT-3′), 0.2X SyBr Green I (Invitrogen, Carlsbad, CA.USA), 5 mM DTT 
(Sigma-Aldrich Saint-Louis MI, USA), 1% DMSO (Sigma-Aldrich), 0.2 mM of each dNTP (Fermentas, Waltham, 
MA.USA), and 1.25 U AmpliTaq Gold DNA polymerase (Applied Biosystems, Waltham, MA.USA) in a total 
volume of 15 µl AmpliTaq Gold Buffer II supplemented with 1.5 mM  MgCl2. The Hgb reaction mix included 
300 nM Hgb1 primer (5′-GCT TCT GAC ACA ACT GTG TTC ACT AGC-3′) and Hgb2 primer (5′-CAC CAA CTT 
CAT CCA CGT TCACC-3′) in a total volume of 15 µl of iQ SyBrGreen supermix (BioRad). The cycling conditions 
for telomere amplification were 10 min at 95 °C, followed by 25 cycles at 95 °C for 15 s and 54 °C for 2 min with 
signal acquisition. The cycling conditions for Hgb amplification were 95 °C for 10 min, followed by 35 cycles at 
95 °C for 15 s, 58 °C for 20 s, and 72 °C for 20 s with signal acquisition. Reactions were performed with a CFX384 
Real-Time PCR Detection System (Bio-Rad Hercules, Ca., USA). Melt-curve analysis was performed at the end 
of the run to ensure specific primer binding.
We used the Bio-Rad CFX Manager software to perform quality control. Samples with a standard deviation 
of more than 0.5 between triplicates were omitted from analysis. Plate effect was considered by analyzing five 
genomic DNA control samples on every plate. We normalized the telomere and Hgb signal values separately 
to the mean of these control samples before taking the T/S ratio. The control samples were used for calculating 
the coefficient of variation (CV) values, which was 8.42%. Samples with Z-scores < − 3.0 or > 3.0 were removed 
as outliers. From 1421 samples, 16 (1.1% of total sample) were discarded as outliers, and thus a total of 1405 
samples were used.
Statistical analyses.  We used linear regression model with Leukocyte Telomere length as a dependent 
variable and maternal anxiety, depression, stress, BMI, Sleep, qPCR analysis plate, maternal smoking, and 
childs’ gestational age at birth and child’s gender as explanatory variables. Due to high intercorrelation between 
PSS, CESD, and STAI, they were analysed separately in order to avoid collinearity bias (correlation coefficients 
between 0.57 and 0.61, p < 0.001). CESD and STAI scores were ln transformated in order to obtain better fit for 
linear regression. All analyses were performed using SPSS v.24 IBM, Armonk, NY, USA.
Power analysis was performed using R software (R ≥ 3.5.1) with specific algorithms implemented in R package 
“pwr”58 and for FDR correction we used R-package “p.adjust.”59. We took effect-size estimates from reference 
 publications22,26,27,32 and set the α error level to < 0.05. We also calculated minimum effect size detectable with 
80% likelihood (α = 5%) using otherwise the same parameters.
Data availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.
Table 5.  Power analysis. Power refers to the calculated probability to detect a given effect with a given sample 
size, e.g. it describes the changes to find an effect previously found with a given sample size.
Variable Publication Effect size from reference publication Power (n)
Minimun effect size detectable with 80% 
power
Body mass index BMI
Martens DS, Plusquin M, Gyselaers W, et.al: 
Maternal pre-pregnancy body mass index and 
newborn telomere length. BMC Med. 2016 Oct 
18;14(1):148 27
r = − 0.11 0.999 (1351) 0.07
Smoking
Bosquet E M, Bollati V, Sideridis G, et.al: Sex 
differences in effects of maternal risk and 
protective factors in childhood and pregnancy 
on newborn telomere length. Psychoneuroen-
docrinology. 2018 Sep;95:74–85 23
r = − 0.18 0.999 (1387) 0.07
Depression
Bosquet E M, Bollati V, Sideridis G, et.al: Sex 
differences in effects of maternal risk and 
protective factors in childhood and pregnancy 
on newborn telomere length. Psychoneuroen-
docrinology. 2018 Sep;95:74–85 26
r = 0.24 1 (1348) 0.07
Sleep
Salihu HM, King L, Patel P et. al: Association 
between maternal symptoms of sleep disor-
dered breathing and fetal telomere length. 
Sleep. 2015 Apr 1;38(4):559–66 32
r = 0.375  = 1 (1392) 0.07
Stress
Send TS, Gilles M, Codd V, et. al: Telomere 
Length in Newborns is Related to Maternal 
Stress During Pregnancy. Neuropsychophar-
macology. 2017 Nov;42(12):2407–2413 22
r = 0.14 0.999 (1392) 0.07
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